Chronopharmacology and Mechanism of Antitumor Effect of Erlotinib in Lewis Tumor-Bearing Mice
Figure 5
Influence of dosing times on P-AKT and AKT protein expression (A) or relative P-AKT and AKT protein expression (B and C) in tumor masses after erlotinib (60 mg/kg) administration.
Each value is the mean with SD of six mice. *P<0.05 when compared with the model group.